The Global Nasogastric Intubation Market Size accounted for USD 614.2 Million in 2023 and is estimated to achieve a market size of USD 1,142.9 Million by 2032 growing at a CAGR of 7.2% from 2024 to 2032.

Nasogastric Intubation Market Highlights

• Global nasogastric intubation market revenue is poised to garner USD 1,142.9 million by 2032 with a CAGR of 7.2% from 2024 to 2032
• North America nasogastric intubation market value occupied around USD 239.54 million in 2023
• Asia-Pacific nasogastric intubation market growth will record a CAGR of more than 7.6% from 2024 to 2032
• Based on patient type, the adult sub-segment generated 37% market share in 2023
• Among end-use, the hospitals sub-segment generated 48% of the market share in 2023
• Development of biocompatible and comfortable NG tubes with anti-clogging features to enhance patient comfort and reduce complications is the nasogastric intubation market trend that fuels the industry demand

Nasogastric intubation is a medical operation that includes passing a thin, flexible tube (nasogastric tube or NG tube) via the nose, down the esophagus, and into the stomach. It is widely used to feed patients who are unable to eat by mouth, as well as to administer medications and nutritional supplements. It also aids in the drainage of stomach contents, such as excess gas or liquids, which helps to ease discomfort and prevent aspiration.

Cleveland Clinic mentioned about some advantages of a nasogastric tube. The NG tube does not require surgery and may be inserted quickly and safely in most patients. This is especially useful in an emergency, such as hazardous ingestion, if you need your stomach pumped. It enables individuals in poor condition to benefit from enteral feeding without requiring surgery. It also has useful short-term applications, such as stomach decompression.

Global Nasogastric Intubation Market Dynamics

Market Drivers

• Increasing prevalence of chronic gastrointestinal disorders requiring enteral feeding
• Growing aging population with swallowing difficulties and nutritional needs
• Rising demand for minimally invasive procedures in healthcare

Market Restraints

• Risk of complications such as nasal irritation, sinusitis, and esophageal injury
• Discomfort and psychological resistance among patients
• Availability of alternative feeding methods like gastrostomy tubes

Market Opportunities

• Technological advancements in tube materials for enhanced patient comfort
• Growing healthcare infrastructure in emerging markets
• Increasing awareness and acceptance of home-based enteral nutrition

Nasogastric Intubation Market Report Coverage

Nasogastric Intubation Market Insights

The increasing prevalence of gastrointestinal diseases such as dysphagia, gastroesophageal reflux, and malignancy demands the use of nasogastric intubation for feeding and medicine delivery. For example, the National Institute of Health reports that the increased incidence of gastrointestinal (GI) cancers, such as stomach, liver, esophageal, pancreatic, and colorectal cancers, is connected to lifestyle changes associated with socioeconomic development. Shifts from traditional to Western diets, greater use of processed foods, and the subsequent obesity and metabolic problems are all significant contributions. These dietary and lifestyle changes, combined with other hazardous practices, are contributing to the rising occurrence of gastrointestinal malignancies in the context of modern societal developments. As a result, patients with these chronic conditions frequently require long-term enteral feeding, which increases demand for the nasogastric tube market.

As the world's population ages, the prevalence of age-related illnesses such as stroke, Parkinson's disease, and dementia rises, causing swallowing problems (dysphagia). The National Institute of Health estimates the age-adjusted cumulative incidence of stroke to be 145/100,000 people per year. The incidence of stroke grew gradually as people aged. The cumulative incidence of stroke was greater among women (178/100,000) than men (117/100,000). Nasogastric intubation is a safe and successful way to feed and provide medication to elderly people with poor swallowing. The growing elderly population drives growth in the nasogastric tube market.

Nasogastric intubation can lead to consequences such as nasal irritation, sinus infections, esophageal damage, and even aspiration pneumonia. These hazards, combined with patient discomfort and psychological resistance, limit its general acceptability. Healthcare professionals and patients may prefer other feeding methods to prevent these issues, limiting nasogastric tube market growth.

Innovations in nasogastric tube materials, such as softer, biocompatible, and antimicrobial coatings, improve patient comfort while lowering infection risks. The National Institute of Health described Sahu's three-in-one procedure as a unique technique for inserting a nasogastric (NG) tube. Sahu's three-in-one approach improves NG tube placement accuracy by offering improved visualization and lowering the chance of airway misplacement, hence improving patient safety and procedural efficiency. These developments improve patient compliance and safety, hence increasing the nasogastric tube market potential.

Nasogastric Intubation Market Segmentation

The worldwide market for nasogastric intubation is split based on product, patient type, indication, end-user, and geography.

Nasogastric Intubation Market By Product

• Levin Tube
• Salem Sump Tube
• Moss Tube
• Others

According to the nasogastric intubation industry analysis, levin tubes are the most used product type due to their adaptability and widespread application for stomach decompression, feeding, and drug administration. Its straightforward design, ease of insertion, and affordability make it a popular choice among healthcare providers. The tube's availability in a variety of sizes meets a wide range of patient needs, making it more adaptable in clinical settings. Furthermore, its efficacy in short-term use and routine stomach drainage contributes to its popularity in hospitals and emergency rooms.

Nasogastric Intubation Market By Patient Type

• Adult
• Pediatric
• Geriatric
• Neonates & Infants

According to the nasogastric intubation industry analysis, adult segment is dominant due to the high frequency of chronic diseases such as cancer, neurological disorders, and gastrointestinal ailments among adults. These health conditions frequently necessitate long-term enteral nutrition and drug delivery via nasogastric tubes. Furthermore, age-related swallowing issues in the senior population increase demand in this market. Adult hospitalizations and surgical procedures have increased, contributing to the widespread use of nasogastric intubation for nutritional assistance and post-operative care.

Nasogastric Intubation Market By Indication

• Dysphagia
• Stomach Cancer
• Chronic Kidney Disease
• Esophageal Cancer
• IBD (Inflammatory Bowel Disease)
• Others

According to the nasogastric intubation market forecast, Dysphagia, or difficulty swallowing, is quickly driving industry growth as it becomes more common among the elderly and people with neurological illnesses such as stroke and Parkinson's disease. According to the National Institutes of Health, the elderly are more likely to acquire dysphagia because ailments affecting the swallowing mechanism are more common in this age group. Nasogastric tubes provide a safe and effective method of administering nutrition and medication to those who are unable to swallow securely. Furthermore, the growing global elderly population contributes to an increased demand for enteral feeding options in dysphagia cases.

Nasogastric intubation End-User

• Hospitals
• Homecare Setting
• Geriatric Institute
• Others

According to the nasogastric intubation market forecast, hospitals are the primary end consumers due to the large volume of acute care, surgical procedures, and critical care situations that require enteral feeding and stomach decompression. They have excellent medical infrastructure and trained healthcare experts who can safely execute nasogastric intubation. Hospitals also treat difficult patient disorders like as severe dysphagia and post-operative rehabilitation, which require both short-term and long-term nutritional care. Furthermore, the availability of specialist units such as intensive care and emergency departments raises the demand for nasogastric tubes in hospital settings.

Nasogastric Intubation Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of LATAM

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)

Nasogastric Intubation Market Regional Analysis

For several reasons, North America dominates the nasogastric tube market thanks to its strong healthcare infrastructure and widespread use of enteral feeding options. Furthermore, an increasing elderly population with chronic conditions increases the demand for nasogastric tubes for long-term nutritional support. According to the US Department of Health and Human Services, an estimated 129 million people in the United States suffer from at least one severe chronic condition (for example, heart disease, cancer, diabetes, obesity, or hypertension). The presence of major medical device manufacturers and well-established regulatory frameworks promotes product safety and innovation.

Asia-Pacific is the fastest-growing market for nasogastric tubes, owing to its huge population and rising frequency of gastrointestinal illnesses. Economic expansion and rising healthcare costs increase access to medical gadgets and enteral feeding options. Government measures to improve healthcare infrastructure, as well as increased knowledge of nutritional management, all contribute to the growth of the nasogastric tube market.

Nasogastric Intubation Market Players

Some of the top nasogastric intubation companies offered in our report includes Poly Medicure Limited, BD, Cardinal Health, Vygon, Angiplast Pvt. Ltd., Medtronic, Andersen Products Inc., Baihe Medical, QMD, and Securmed.

TABLE OF CONTENT